Diseases, Conditions, Syndromes

Tapeworm DNA contains drug weak spots

For the first time, researchers have mapped the genomes of tapeworms to reveal potential drug targets on which existing drugs could act. The genomes provide a new resource that offers faster ways to develop urgently needed ...

Diseases, Conditions, Syndromes

WHO urges billions to fight neglected tropical diseases

The World Health Organization on Thursday urged countries to invest billions of dollars to tackle 17 neglected tropical diseases—including dengue fever, leprosy and sleeping sickness—which kill 500,000 people globally ...

Diseases, Conditions, Syndromes

Heat shock protein appears to turn on Schistosoma invasion

A protein known for helping cells withstand stress may also act as a switch that triggers free-swimming Schistosoma larvae to begin penetrating the skin and transforming into the parasitic flatworms that burden more than ...

Immunology

Sleeping sickness by stealth

(Medical Xpress)—Stealth is a well-known concept in military tactics. Almost since the invention of radar, the hunt began for counter-technologies to hide aircraft and missiles from detection – most successfully by modifying ...

Diseases, Conditions, Syndromes

Fralin entomologists map out the genetics behind a deadly disease

(Medical Xpress)—Stopping the spread of dengue infection— a potentially fatal tropical disease transmitted by the Aedes aegypti mosquito— could be one of the biggest challenges of our time. About half of the human ...

page 1 from 5

The neglected diseases are a group of tropical infections which are especially endemic in low-income populations in developing regions of Africa, Asia, and the Americas. Different organizations define the set of diseases differently. In sub-Saharan Africa, the impact of these diseases as a group is comparable to malaria and tuberculosis. Some of these diseases have known preventive measures or acute medical treatments which are available in the developed world but which are not universally available in poorer areas. In some cases, the treatments are relatively inexpensive. For example, the treatment for schistosomiasis is USD $0.20 per child per year. Nevertheless, control of neglected diseases[clarification needed] is estimated to require funding of between US$2 billion to US$3 billion over the next five to seven years.

These diseases are contrasted with the big three diseases (HIV/AIDS, tuberculosis, and malaria), which generally receive greater treatment and research funding. The neglected diseases can also make HIV/AIDS and tuberculosis more deadly. However, some pharmaceutical companies have committed to donating all the drug therapies required and mass drug administration has been successfully accomplished in several countries.

This text uses material from Wikipedia licensed under CC BY-SA